Evidence map›Paper›PMID 26202119›Full record

ArticleJournal of clinical microbiology2015

Ultradeep Sequencing for Detection of Quasispecies Variants in the Major Hydrophilic Region of Hepatitis B Virus in Indonesian Patients.

Laura Navika Yamani, Yoshihiko Yano, Takako Utsumi, Juniastuti, Hadi Wandono, Doddy Widjanarko, Ari Triantanoe, Widya Wasityastuti, Yujiao Liang, Rina Okada and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Laura Navika YamaniCenter for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan Indonesia-Japan Collaborative Research Centre for Emerging and Reemerging Infectious Disease, Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
Yoshihiko YanoCenter for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan Department of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Japan yanoyo@med.kobe-u.ac.jp.
Takako UtsumiCenter for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan Indonesia-Japan Collaborative Research Centre for Emerging and Reemerging Infectious Disease, Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
JuniastutiIndonesia-Japan Collaborative Research Centre for Emerging and Reemerging Infectious Disease, Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
Hadi WandonoDepartment of Gastroenterology and Hepatology, Hajj General Hospital, Surabaya, Indonesia.
Doddy WidjanarkoDepartment of Internal Medicine, Dr. Mohammad Soewandhie General Hospital, Surabaya, Indonesia.
Ari TriantanoeDepartment of Internal Medicine, Dr. Mohammad Soewandhie General Hospital, Surabaya, Indonesia.
Widya WasityastutiCenter for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan Department of Physiology, Faculty of Medicine, Dr. Sardjito Hospital, Gadjah Mada University, Yogyakarta, Indonesia.
Yujiao LiangCenter for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.
Rina OkadaDepartment of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Japan.
Toshihito TanahashiDepartment of Medical Pharmaceutics, Kobe Pharmaceutical University, Kobe, Japan.
Yoshiki MurakamiDepartment of Hepatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Takeshi AzumaDepartment of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Japan.
SoetjiptoIndonesia-Japan Collaborative Research Centre for Emerging and Reemerging Infectious Disease, Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
Maria Inge LusidaIndonesia-Japan Collaborative Research Centre for Emerging and Reemerging Infectious Disease, Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
Yoshitake HayashiCenter for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.
Kobe University · JPAirlangga University · IDKobe Pharmaceutical University · JPOsaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quasispecies of hepatitis B virus (HBV) with variations in the major hydrophilic region (MHR) of the HBV surface antigen (HBsAg) can evolve during infection, allowing HBV to evade neutralizing antibodies. These escape variants may contribute to chronic infections. In this study, we looked for MHR variants in HBV quasispecies using ultradeep sequencing and evaluated the relationship between these variants and clinical manifestations in infected patients. We enrolled 30 Indonesian patients with hepatitis B infection (11 with chronic hepatitis and 19 with advanced liver disease). The most common subgenotype/subtype of HBV was B3/adw (97%). The HBsAg titer was lower in patients with advanced liver disease than that in patients with chronic hepatitis. The MHR variants were grouped based on the percentage of the viral population affected: major, ≥20% of the total population; intermediate, 5% to <20%; and minor, 1% to <5%. The rates of MHR variation that were present in the major and intermediate viral population were significantly greater in patients with advanced liver disease than those in chronic patients. The most frequent MHR variants related to immune evasion in the major and intermediate populations were P120Q/T, T123A, P127T, Q129H/R, M133L/T, and G145R. The major population of MHR variants causing impaired of HBsAg secretion (e.g., G119R, Q129R, T140I, and G145R) was detected only in advanced liver disease patients. This is the first study to use ultradeep sequencing for the detection of MHR variants of HBV quasispecies in Indonesian patients. We found that a greater number of MHR variations was related to disease severity and reduced likelihood of HBsAg titer.

Indexed as

Genetic VariationAdultAgedAmino Acid SubstitutionFemaleGene FrequencyHepatitis BHepatitis B Surface AntigensHepatitis B virusHigh-Throughput Nucleotide SequencingHumansIndonesiaMaleMiddle AgedSequence Analysis, DNAHepatitis B Surface Antigens

Identifiers

PMID26202119
PMCPMC4572547
OpenAlexW1917208912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.